Tobacco is the leading underlying single cause of death worldwide. In 2016, tobacco use caused over 7.1 million deaths mostly related to lung and heart disease, cancer, and stroke. Every year, on May 31, people and organizations mark World No Tobacco Day, by highlighting the health and other risks associated with […]
Respiratory
Vertex Awards $400,000 in Scholarships to CF Patients and Their Immediate Family Members
All in for CF Scholarship Program Doubles to Help 80 Recipients Pursue Higher Education Vertex Pharmaceuticals Incorporated announced the recipients of scholarships as part of its second All in for CF Scholarship program. Each of the 80 scholarship recipients will be awarded $5,000 for the 2018-2019 academic year. The Vertex […]
Study Says: Bronchiectasis Exacerbations Significantly Reduced with HFCWO Therapy
Electromed, Inc. recently announced the results of a longitudinal outcome-based study published in Respiratory Therapy: The Journal of Pulmonary Technique. The longitudinal study shows that high-frequency chest wall oscillation (“HFCWO”) therapy with the SmartVest® Airway Clearance System significantly reduces bronchiectasis-related exacerbations including the need for antibiotics, emergency department visits, and […]
Driving Value With Home NIV: Discover How You Could Save Your Organization Millions
You may already know the clinical benefits of home NIV, but now discover the significant cost savings this new approach could bring to your organization. Emerging evidence has reinforced the use of home-based noninvasive ventilation (NIV) to treat patients with chronic hypercapnic COPD. This new methodology was proven in the […]
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for Patients With COPD
Once-Daily Trelegy Ellipta Gains Expanded Indication in the US for the Treatment of Patients With COPD GlaxoSmithKline plc and Innoviva, Inc. today announced that the US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol ‘FF/UMEC/VI’), which means Trelegy Ellipta can now be used […]
Delivery System Considerations for Inhaled Medications Undermined in Patients with COPD
Researchers from the American College of Chest Physicians conducted the Delivery Makes a Difference (DMaD) project to obtain a better understanding of health care provider and patient perspectives about the role of inhalation delivery devices in COPD. This study also examined the nature of both patient and physician understanding and the educational […]
Mount Sinai − National Jewish Health Respiratory Institute Opens Second Location
The Mount Sinai – National Jewish Health Respiratory Institute marked the official opening of its second location on Monday, April 16, 2018, with a ribbon-cutting ceremony. The new practice, on the second floor of Mount Sinai Union Square, the Mount Sinai Health System’s comprehensive ambulatory care center at 10 Union […]
New Blood Test Found to Predict Onset of TB Up to Two Years in Advance
Focusing on people who lived with someone with active TB, the research team enrolled 4,466 HIV-negative, healthy study participants from the households of 1,098 index cases (people with active TB, who allowed the researchers to enroll members of their household who did not have TB in its active stage). Blood […]
ATS Responds to FDA’s Latest Proposal to Reduce Nicotine Levels in Cigarettes
It is with great interest, and some skepticism, that the ATS views the FDA’s recent proposal to reduce nicotine levels in cigarettes to non-addictive levels. In a perfect world, creating a non-addictive cigarette product might be the “silver bullet” we are looking for to reduce the death and disease caused by tobacco […]
COPD: Eliminating Stigma
The stigma of COPD can prevent patients from coming forward. Here are our top insider tips on how you can make the difference. Few chronic illnesses carry a lack of awareness and a stigma like COPD. Caused primarily by tobacco use, COPD can evoke feelings of guilt, shame and regret […]













